Xu, Jingying <br/><br/>
CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer.  [electronic resource] 

 -  Cancer research  May 2013 
 - 2782-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-12-3981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Movement<br/>Chromatin--metabolism<br/>DNA Damage<br/>Humans<br/>Immunohistochemistry--methods<br/>Macrophages--cytology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Microscopy, Fluorescence--methods<br/>Myeloid Cells--cytology<br/>Neoplasm Transplantation<br/>Prostatic Neoplasms--metabolism<br/>Radiotherapy--methods<br/>Receptor, Macrophage Colony-Stimulating Factor--metabolism<br/>Signal Transduction